● Private placements for private companies
● Private placements for public companies
● Debt financings
● Structured financings
● Royalty monetizations
● Investor Relations campaigns
Longcross has outstanding relations with public and private life science investors around the world. This capability arose from the firm’s Managing Partner, Dr Tim Wilson’s, position as a highly ranked biotechnology analyst on Wall Street and in the City of London for many years. He has raised over $2 billion for clients and taken 21 companies public including the first biotechnology IPOs in Germany, Denmark and Italy as well as many IPOs in the US. Dr Wilson also has considerable experience with other forms of financing including secondary offerings, convertible offerings, private placements, royalty monetizations and venture financings.
So, whether you need access to Institutional Investors, the US hedge fund community or life science venture capitalists, Longcross has the relationships, experience and knowledge to bring about a successful outcome.